Oxytocin in the human - Regulation of derivations and destinations

European Journal of Endocrinology

Volumn 137, Issue 6, 1997, Pages 559-571

  Evans, John J ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CHRISTCHURCH WOMEN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CHORIONIC GONADOTROPIN; CLOMIPRAMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; ENDORPHIN; ESTRADIOL; FOLLITROPIN; GLUCOSE; GONADORELIN; GONADOTROPIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROCORTISONE; HYDROGEN PEROXIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; NALOXONE; NEUROPEPTIDE; NEUROTRANSMITTER; OXYTOCIN; OXYTOCIN RECEPTOR; PHOSPHOLIPASE C; PROGESTERONE; PROLACTIN; PROOPIOMELANOCORTIN; PROSTAGLANDIN F2 ALPHA; RECEPTOR SUBTYPE; UNINDEXED DRUG; VASOPRESSIN;

ADENOHYPOPHYSIS; ADIPOCYTE; ADRENAL GLAND; BEHAVIOR; BRAIN; BREAST; FEEDING; GENE; HORMONAL REGULATION; HUMAN; LACTATION; NOCICEPTION; NONHUMAN; OBSESSION; OVARY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; TESTIS; THYMUS; UTERUS;

ADRENAL GLANDS; ANIMALS; APPETITE; BEHAVIOR; BRAIN; BREAST; FEMALE; GENES; HUMANS; LACTATION; MALE; OVARY; OXYTOCIN; PAIN; PANCREAS; PITUITARY GLAND, ANTERIOR; RECEPTORS, OXYTOCIN; REPRODUCTION; TESTIS; THYMUS GLAND; UTERUS;

EID: 0031467096     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370559     Document Type: Review

References (136)

1. Pickford M. Some extra-uterine actions of oxytocin. In Oxytocin, pp 68-79. Eds R Caldeyro-Barcia and H Heller. Oxford: Pergamon Press, 1961.
2. du Vigneaud V, Ressler C & Trippett S. The sequence of amino acids in oxytocin with a proposal for the structure of oxytocin. Journal of Biological Chemistry 1953 205 949-957.
3. du Vigneaud V, Ressler C, Swan JM, Roberts CW, Katsoyannis PG & Gordon S. The synthesis of an octapeptide amide with the hormonal activity of oxytocin. Journal of the American Chemical Society 1953 75 4879-4880.
4. Rao VVNG, Löffler C, Battey J & Hansmann I. The human gene for oxytocin-neurophysin I (OXT) is physically mapped to chromosome 20p13 by in situ hybridization. Cytogenetics and Cell Genetics 1992 61 271-273.
5. Gainer H, Jeong S-W, Witt DM & Chin H. Strategies for cell biological studies in oxytocinergic neurons. Advances in Experimental Medicine and Biology 1995 395 1-8.
6. Kimura T, Makino Y, Saji F, Takemura M, Inoue T, Kikuchi T et al. Molecular characterization of a cloned human oxytocin receptor. European Journal of Endocrinology 1994 131 385-390.
7. Inoue T, Kimura T, Azuma C, Inazawa J, Takemura M, Kikuchi T et al. Structural organisation of the human oxytocin receptor gene. Journal of Biological Chemistry 1994 269 32451-32456.
8. Michelini S, Urbanek M, Dean M & Goldman D. Polymorphism and genetic mapping of the human oxytocin receptor gene on chromosome 3. American Journal of Medical Genetics (Neuropsychiatric Genetics) 1995 60 183-197.
9. Simmons CF, Clancy TE, Quan R & Knoll JHM. The oxytocin receptor gene (OXTR) localizes to human chromosome 3p25 by fluorescence in situ hybridization and PCR analysis of somatic cell hybrids. Genomics 1995 26 623-625.
10. van Kesteren RE, Smit AB, Dirks RW, de With ND, Geraerts WPM & Joosse J. Evolution of the vasopressin/oxytocin superfamily: Characterization of a cDNA encoding a vasopressin-related precursor from the mollusc Lymnaea stagnalis. Neurobiology 1992 89 4593-4597.
11. Mohr E & Richter D. Hypothalamic neuropeptide genes. Aspects of evolution expression and subcellular mRNA distribution. Annals of the New York Academy of Sciences 1993 689 50-58.
12. Sukhov RR, Walker LC, Rance NE, Price DL & Young WS III. Vasopressin and oxytocin gene expression in the human hypothalamus. Journal of Comparative Neurology 1993 337 295-306.
13. Sofroniew MV, Weindl A, Schrell U & Wetzstein R. Immunohistochemistry of vasopressin, oxytocin and neurophysin in the hypothalamus and extrahypothalamic regions of the human and primate brain. Acta Histochemica 1981 24 (Suppl) 79-95.
14. Jenkins JS, Ang VTY, Hawthorn J, Rossor MN & Iversen LL. Vasopressin, oxytocin and neurophysins in the human brain and spinal cord. Brain Research 1984 291 111-117.
15. Burbach JPH, Adan RAH & de Bree FM. Regulation of oxytocin gene expression and forms of oxytocin in the brain. Annals of the New York Academy of Sciences 1992 652 1-13.
16. Richard S & Zingg HH. The human oxytocin gene promoter is regulated by estrogens. Journal of Clinical Biochemistry 1990 11 6098-6103.
17. Zingg HH & Lefebvre DL. Oxytocin mRNA: increase of polyadenylate tail size during pregnancy and lactation. Molecular and Cellular Endocrinology 1989 65 59-62.
18. Amico JA, Tenicela R, Johnston J & Robinson AG. A time-dependent peak of oxytocin exists in cerebrospinal fluid but not in plasma of humans. Journal of Clinical Endocrinology and Metabolism 1983 57 947-951.
19. Stock S, Silber M & Unväs-Moberg K. Elevated plasma levels of oxytocin in women taking low-dose oral contraceptives. Acta Obstetrica Gynecologica Scandinavica 1989 68 75-78.
20. Bossmar T, Forsling M & Åkerlund M. Circulating oxytocin and vasopressin is influenced by ovarian steroid replacement in women. Acta Obstetrica et Gynecologica Scandinavica 1995 74 544-548.
21. Amico JA, Ervin MG, Leake RD, Fisher DA, Finn FM & Robinson AG. A novel oxytocin-like and vasotocin-like peptide in human plasma after administration of estrogen. Journal of Clinical Endocrinology and Metabolism 1985 60 5-12.
22. Coiro V & Chiodera P. Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man. Neuroendocrinology 1991 53 209-213.
23. Manning AB, Chronwall BM & Millington WR. POMC-derived peptide immunoreactivity in neural lobe axons of the human pituitary. Peptides 1993 14 857-860.
24. Tribollet E, Dubois-Dauphin M, Dreifuss JJ, Barberis C & Jard S. Oxytocin receptors in the central nervous system. Distribution development and species differences. Annals of the New York Academy of Sciences 1992 652 29-38.
25. Coirini H, Johnson AE, Schumacher M & McEwen BS. Sex differences in the regulation of oxytocin receptors by ovarian steroids in the ventromedial hypothalamus of the rat. Neuroendocrinology 1992 55 269-275.
26. Weitzman RE. The effect of nursing on neurohypophyseal hormone and prolactin secretion in human subjects. Journal of Clinical Endocrinology and Metabolism 1980 51 836-839.
27. Dawood MY, Khan-Dawood FS, Wahi RS & Fuchs F. Oxytocin release and plasma anterior pituitary and gonadal hormones in women during lactation. Journal of Clinical Endocrinology and Metabolism 1981 52 678-683.
28. Cross BA. The posterior pituitary gland in relation to reproduction and lactation. British Medical Bulletin 1955 11 151-155.
29. McNeilly AS, Robinson ICAF, Houston MJ & Howie PW. Release of oxytocin and prolactin in response to suckling. British Medical Journal 1983 286 257-259.
30. Seitz PK, Cooper KM, Ives KL, Ishizuka J, Townsend CM, Rajaraman S et al. Parathyroid hormone-related peptide production and action in myoepithelial cell line derived from normal human breast. Endocrinology 1993 133 1116-1124.
31. Sala NL. The milk-ejecting effect induced by oxytocin and vasopressin during human pregnancy. American Journal of Obstetrics and Gynecology 1964 89 626-634.
32. Seoud MA-F, Sayigh R, Khayat H, Ali LA & Azoury RS. Electrical breast stimulation oxytocin prolactin and uterine response. Journal of Reproductive Medicine 1993 38 438-442.
33. Uedo T, Yokoyama Y, Irahara M & Aono T. Influence of psychological stress on suckling-induced pulsatile oxytocin release. Obstetrics and Gynecology 1994 84 259-262.
34. Chiodera P, Salvarani C, Bacchi-Modena A, Spallanzani R, Cigarini C, Alboni A et al. Relationship between plasma profiles of oxytocin and adrenocorticotrophic hormone during suckling or breast stimulation in women. Hormone Research 1991 35 119-123.
35. Amico JA, Johnston JM & Vagnuccim AH. Suckling-induced attenuation of plasma cortisol concentrations in postpartum lactating women. Endocrine Research 1994 20 79-87.
36. Altemus M, Deuster PA, Galliven E, Carter CS & Gold PW. Suppression of hypothalamic-pituitary-adrenal axis responses to stress in lactating women. Journal of Clinical Endocrinology and Metabolism 1995 80 2954-2959.
37. Coiro V, Alboni A, Gramellini D, Cigarini C, Bianconi L, Pignatti D et al. Inhibition by ethanol of the oxytocin response to breast stimulation in normal women and the role of endogenous opioids. Acta Endocrinologica 1992 126 213-216.
38. Cassoni P, Sapino A, Negro F & Bussolati G. Oxytocin inhibits proliferation of human breast cancer cell lines. Virchows Archiv 1994 425 467-472.
39. Ito Y, Kobayashi T, Kimura T, Matsuura N, Wakasugi E, Takeda T et al. Investigation of the oxytocin receptor expressions in human breast cancer tissue. Endocrinology 1996 137 773-779.
40. Taylor AH, Ang VTY, Jenkins JS, Silverlight JJ, Coombes RC & Luqmani YA. Interaction of vasopressin and oxytocin with human breast carcinoma cells. Cancer Research 1990 50 7882-7886.
41. Murrell TG. The potential for oxytocin (OT) to prevent breast cancer: a hypothesis. Breast Cancer Research and Treatment 1995 35 225-229.
42. Kimura T, Takemura M, Nomura S, Nobunaga T, Kubota Y, Inoue T et al. Expression of oxytocin receptor in human pregnant myometrium. Endocrinology 1996 137 780-785.
43. Phaneuf S, Europe-Finner GN, Carrasco MP, Hamilton CH & Lopez-Bernal A. Oxytocin signalling in human myometrium. Advances in Experimental Medicine and Biology 1995 395 453-467.
44. Sanborn BM, Qian A, Ku CY, Wen Y, Anwer K, Monga M et al. Mechanisms regulating oxytocin receptor coupling to phospholipase C in rat and human myometrium. Advances in Experimental Medicine and Biology 1995 395 469-479.
45. Fu X, Rezapour M, Lofgren M, Ulmsten U & Bäckstrom T. Antitachyphylactic effects of progesterone and oxytocin on term human myometrial contractile activity in vitro. Obstetrics and Gynaecology 1993 82 532-538.
46. Quartero HWP, Noort WA, Fry CH & Kierse MJNC. Role of prostaglandins and leukotrienes in the synergistic effect of oxytocin and corticotropin-releasing hormone (CRH) on the contraction force in human gestational myometrium. Prostaglandins 1991 42 137-150.
47. Goodwin TM, Millar L, North L, Abrams LS, Weglein RC & Holland ML. The pharmokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions. American Journal of Obstetrics and Gynecology 1995 173 913-917.
48. Åkerlund M. The role of oxytocin and vasopressin in the initiation of preterm and term labour as well as primary dysmenorrhoea. Regulatory Peptides 1993 45 187-191.
49. Fuchs A-R, Fuchs F & Soloff MS. Oxytocin receptors in nonpregnant human uterus. Journal of Clinical Endocrinology and Metabolism 1985 60 37-41.
50. Takemura M, Nomura S, Kimura T, Inoue T, Onoue H, Azuma C et al. Expression and localization of oxytocin receptor gene in human uterine endometrium in relation to the menstrual cycle. Endocrinology 1993 132 1830-1835.
51. Baker PN, Peat ML, Symonds EM & Maynard PV. Endometrial oxytocin binding sites in normal women and in subfertile patients Postgraduate Medical Journal 1990 66 195-199.
52. Maggi M, Magini A, Fiscella A, Giannini S, Fantoni G, Toffoletti F et al. Sex steroid modulation of neurohypophysial hormone receptors in human nonpregnant myometrium. Journal of Clinical Endocrinology and Metabolism 1992 74 385-392.
53. Clayton RN. Mechanism of GnRH action in gonadotrophs. Human Reproduction 1988 3 479-483.
54. Dalkin AC, Haisenleder DJ, Yasin M, Gilrain JT & Marshall JC. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin. Endocrinology 1996 137 548-554.
55. Arpin-Bott MP, Waltisperger E, Freund-Mercier MJ & Stoekel ME. Two oxytocin-binding site subtypes in rat kidney: pharmacological characterisation, ontogeny and localization by in vitro and in vivo autoradiography. Journal of Endocrinology 1997 153 49-59.
56. Pisegna JR & Wank SA. Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C. Journal of Biological Chemistry 1996 29 17267-17274.
57. Elshourbagy NA, Adamou JE, Gagnon AW, Wu H-L, Pullen M & Nambi P. Molecular characterization of a novel human endothelin receptor splice variant. Journal of Biological Chemistry 1996 412 5300-25307.
58. Clauser E, Curnow KM, Davies E, Conchon S, Teutsch B, Vianello B et al. Angiotensin II receptors: protein and gene structures expression and potential pathological involvements. European Journal of Endocrinology 1996 134 403-411.
59. Plevrakis I, Clamagirand C & Pontonnier G. Oxytocin biosynthesis in serum-free cultures of human granulosa cells. Journal of Endocrinology 1990 124 R5-R8.
60. Guillou M-D, Camier M & Clamagirand C. Evidence for the presence of pro-oxytocin/neurophysin-converting enzyme in the human ovary. Journal of Endocrinology 1994 142 345-352.
61. Clamagirand C, Plevrakis I, Bussenot I, Parinaud J, Vieitez G & Grandjean H. The effect of oxytocin on oestradiol-17β and testosterone secretion by cultured human granulosa cells. Human Reproduction 1991 6 774-778.
62. 2+ levels and progesterone release by human granulosa-lutein cells. Journal of Clinical Endocrinology and Metabolism 1993 77 1209-1214.
63. Lopez Bernai A, Bellinger J, Marshall JM, Phaneuf S, Europe-Finner GN, Asbóth G et al. G protein expression and second messenger formation in human granulosa cells. Journal of Reproduction and Fertility 1995 104 77-83.
64. Furuya K, Makimura N, Mitsui C, Ishikawa N, Tokuoka S, Imaizumi E et al. A novel biological aspect of ovarian oxytocin: oxytocin gene expression in cumulus/luteal cells and the effect of oxytocin on embryogenesis in fertilized oocytes. Hormone Research 1994 41 (Suppl 1) 41-47.
65. Furuya K, Mizumoto Y, Makimura N, Mitsui C, Murakami M, Tokuoka S et al. Gene expressions of oxytocin and oxytocin receptor in cumulus cells of human ovary. Hormone Research 1995 44 47-49.
66. Khan-Dawood FS, Yang J, Anwer K & Dawood MY. Bioactive oxytocin in human and baboon corpora lutea. Journal of Endocrinology 1995 147 525-532.
67. Fuchs A-R, Behrens O, Helmer H, Vangsted A, Ivanisevic M, Grifo J et al. Oxytocin and vasopressin biding sites in human and bovine arteries. American Journal of Obstetrics and Gynecology 1990 163 1961-1967.
68. 2α and estradiol within the human corpus luteum. Journal of Clinical Endocrinology and Metabolism 1992 74 306-312.
69. 2α in human corpus luteum? Human Reproduction 1995 10 2320-2324.
70. Nicholson HD, Swann RW, Burford GD, Wathes DC, Porter DG & Pickering BT. Identification of oxytocin and vasopressin in the testis and in adrenal tissue. Regulatory Peptides 1984 8 141-146.
71. Mehta MK, Garde SV & Sheth AR. Occurrence of FSH inhibin and other hypothalamic-pituitary-intestinal hormones in normal fertility subfertility and tumors of human testes. International Journal of Fertility and Menopausal Studies 1995 40 39-46.
72. Ivell R, Furuya K, Brackmann B, Dawood Y & Khan-Dawood F. Expression of the oxytocin and vasopressin genes in human and baboon gonadal tissues. Endocrinology 1990 127 2990-2996.
73. Einspanier A & Ivell R. Oxytocin and oxytocin receptor expression in reproductive tissues of the male marmoset monkey. Biology of Reproduction 1997 56 416-422.
74. Nicholson HD & Jenkin L. Oxytocin and prostatic function. Advances in Experimental Medicine and Biology 1995 395 529-538.
75. Geenen V, Legros J-J, Franchimont P, Baudrihaye M, Defresne M-P & Boniver J. The neuroendocrine thymus: coexistence of oxytocin and neurophysin in the human thymus. Science 1986 232 508-511.
76. Geenan V, Cormann-Goffin N, Martens H, Vandersmissen E, Robert F, Benhida A et al. Thymic neurohypophysial-related peptides and T cell selection. Regulatory Peptides 1993 45 273-278.
77. Martens H, Goxe B & Geenen V. The thymic repertoire of neuroendocrine self-antigens: physiological implications in T-cell life and death. Immunology Today 1996 17 312-317.
78. Anderson-Hunt M & Dennerstein L. Oxytocin and female sexuality. Gynecological and Obstetrical Investigation 1995 40 217-221.
79. Herbert J. Oxytocin and sexual behaviour. British Medical Journal 1994 309 891-892.
80. Carmichael MS, Warburton VL, Dixen J & Davidson JM. Relationships among cardiovascular muscular and oxytocin responses during human sexual activity. Archives of Sexual Behaviour 1994 23 59-79.
81. Carter CS. Oxytocin and sexual behaviour. Neuroscience and Behavioural Reviews 1992 16 131-144.
82. Anderson-Hunt M & Dennerstein L. Increased female sexual response after oxytocin. British Medical Journal 1994 309 929.
83. Legros JJ. Neurohypophyseal peptides and psychopathology. Hormone Research 1992 37 16-21.
84. Pietrowsky R, Braun D, Fehm HL, Pauschinger P & Born J. Vasopressin and oxytocin do not influence early sensory processing but affect mood and activation in man. Peptides 1991 12 1385-1391.
85. 8] vasopressin or oxytocin on cognitive processes in young healthy subjects. Peptides 1992 13 461-468.
86. Fehm-Wolfsdorf G & Born J. Behavioural effects of neurohypophyseal peptides in healthy volunteers: 10 years of research. Peptides 1991 12 1399-1406.
87. Pitman RK, Orr SP & Lasko NB. Effects of intranasal vasopressin and oxytocin on physiologic responding during personal combat imagery in Vietnam veterans with posttraumatic stress disorder. Psychiatry Research 1993 48 107-117.
88. Silber M, Almkvist O, Larsson B & Uvnäs-Moberg K. Temporary peripartal impairment in memory and attention and its possible relation to oxytocin concentration. Life Sciences 1990 47 57-65.
89. Uvnäs-Moberg K, Arn I, Jonsson C-O, Ek S & Nilsonne Å. The relationships between personality traits and plasma gastrin cholecystokinin, somatostatin, insulin and oxytocin levels in healthy women. Journal of Psychosomatic Research 1993 37 581-588.
90. Sanders G, Freillicher J & Lightman SL. Psychological stress of exposure to uncontrollable noise increases plasma oxytocin in high emotionality women. Psychoneuroendocrinology 1990 15 47-58.
91. Swedo SE, Leonard HL, Kruesi MJP, Rettew DC, Listwak SJ, Berrettini W et al. Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Archives of General Psychiatry 1992 49 29-36.
92. Altemus M, Swedo SE, Leonard HL, Richter D, Rubinow DR, Potter et al. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive compulsive disorder with clomipramine. Archives of General Psychiatry 1994 51 794-803.
93. den Boer JA & Westenberg HGM. Oxytocin in obsessive compulsive disorder. Peptides 1992 13 1083-1085.
94. Amico JA, Doll Jr RB, Finn FM, Ervin MG, Leake RD, Fisher DA et al. High pressure liquid chromatographic separation of an oxytocin/arginine vasotocin-like peptide from the plasma of patients with chronic renal failure. Journal of Clinical Endocrinology and Metabolism 1985 60 644-650.
95. Legros JJ, Chiodera P, Geenen V, Smitz S & von Frenckell R. Dose-response relationship between plasma oxytocin and cortisol and adrenocorticotropin concentrations during oxytocin infusion in normal men. Journal of Clinical Endocrinology and Metabolism 1984 58 105-109.
96. Legros JJ, Chiodera P & Demey-Ponsart E. Inhibitory influence of exogenous oxytocin on adrenocorticotropin secretion in normal human subjects. Journal of Clinical Endocrinology and Metabolism 1982 55 1035-1039.
97. Page SR, Ang VTY, Jackson R, White A, Nussey SS & Jenkins JS. The effect of oxytocin infusion on adenohypophyseal function in man. Clinical Endocrinology 1990 32 307-313.
98. Nussey SS, Page SR, Ang VT, Jenkins JS & White A. The effect of oxytocin infusion on adenohypophyseal and adrenal cortical responses to insulin-induced hypoglycaemia. Clinical Endocrinology 1988 29 257-264.
99. Volpi R, Chiodera P, Bianconi L, Marcato A, Cavazzini U, Pignatti D et al. Oxytocin does not modify glucagon-or calcitonin-induced ACTH-cortisol rise in humans. Hormone and Metabolic Research 1989 21 635-637.
100. Evans JJ, Robinson G & Catt KJ. Gonadotrophin-releasing activity of neurohypophysial hormones: I. Potential for modulation of pituitary hormone secretion in rats. Journal of Endocrinology 1989 122 99-106.
101. Robinson G & Evans JJ. Oxytocin has a role in gonadotrophin regulation in rats. Journal of Endocrinology 1990 125 425-432.
102. Hull ML, Reid RA, Evans JJ, Benny PS & Aickin DR. Pre-ovulatory oxytocin administration promotes the onset of the luteinizing hormone surge in human females. Human Reproduction 1995 10 2266-2269.
103. Chiodera P, Coiro V, Volpi R, Maffei ML, Camellini L & Rossi G. Evaluation of oxytocin administration on luteinizing hormone and follicle-stimulating hormone response to luteinizing hormone-releasing hormone during the menstrual cycle of normal women. Fertility and Sterility 1984 42 396-399.
104. Amico JA, Richardson DW & Winters SJ. The effect of oxytocin administration upon the pulsatile secretion of luteinizing hormone in humans. Acta Endocrinologica 1989 121 41-45.
105. Legros JJ & Franchimont P. Serum-gonadotrophins after oxytocin in man. Lancet 1968 2 735.
106. Dawood MY, Ylikorkala O, Trivedi D & Gupta R. Oxytocin levels and disappearance rate and plasma follicle-stimulating hormone and luteinizing hormone after oxytocin infusion in men. Journal of Clinical Endocrinology and Metabolism 1980 50 397-400.
107. Persengiev SP, Raval PJ, Rabinovitch S, Millette CF & Kilpatrick DL. Transcription factor Sp1 is expressed by three different developmentally regulated messenger ribonucleic acids in mouse spermatogenic cells. Endocrinology 1996 137 638-646.
108. 3 cells with rat gonadotropin-releasing hormone receptor complementary deoxyribonucleic acid results in expression of a receptor coupled to cyclic adenosine 3′5′-monophosphate-dependent prolactin release via a G-protein. Endocrinology 1994 135 315-320.
109. MacArthur L & Eiden L. Neuropeptide genes: targets of activity-dependent signal transduction. Peptides 1996 17 721-728.
110. Legros JJ, Chiodera P & Geenen V. Inhibitory action of exogenous oxytocin on plasma cortisol in normal human subjects: evidence of action at the adrenal level. Neuroendocrinology 1988 48 204-206.
111. Heckert LL, Schultz K & Nilson JH. Different composite regulatory elements direct expression of the human a subunit gene to pituitary and placenta. Journal of Biological Chemistry 1995 270 26497-26504.
112. Chang W, Zhou W, Theill LE, Baxter JD & Schaufele F. An activation function in pit-1 required selectively for synergistic transcription. Journal of Biological Chemistry 1996 271 17733-17738.
113. Ang VTT & Jenkins JS. Neurohypophysial hormones in the adrenal medulla. Journal of Clinical Endocrinology and Metabolism 1984 58 688-691.
114. Paolisso G, Pizza G, De Riu S, Marrazzo G, Sgambato S, Giugliano D et al. Effects of oxytocin upon the endocrine pancreas secretion and glucose turnover in normal man. Acta Endocrinologica 1990 123 504-510.
115. Page SR, Ang VTY, Jackson R & Nussey SS. The effect of oxytocin on the plasma glucagon response to insulin-induced hypoglycaemia in man. Diabete et Metabolisme 1990 16 248-252.
116. Chiodera P, Volpi R, Caiazza A, Davoli C, Marchesi C, Papadia C et al. Inhibitory effect of dexamethasone on the oxytocin in response to insulin-induced hypoglycaemia in normal men. Journal of Endocrinological Investigation 1992 15 459-463.
117. Coiro V, Capretti L, Speroni G, Castelli A, Bianconi L, Cavazzini U et al. Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men. Journal of Endocrinological Investigation 1990 13 757-763.
118. Johnson MR, Bower M, Seckl JR & Lightman SL. Neurohypophysial secretion to insulin-induced hypoglycemia and its regulation by endogenous opioids in women. Acta Endocrinologica 1990 122 467-471.
119. Fisher BM, Baylis PH, Thornton S & Frier BM. Arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in type 1 (insulin-dependent) diabetes. Journal of Clinical Endocrinology and Metabolism 1989 68 688-692.
120. Amico JA, Finn FM & Haldar J. Oxytocin and vasopressin are present in human and rat pancreas. American Journal of Medical Sciences 1988 296 303-307.
121. 2-generating system present in human fat-cell plasma membranes is multireceptor-linked and under antagonistic control by hormones and cytokines. Biochemical Journal 1995 307 543-548.
122. Miaskiewicz SL, Stricker EM & Verbalis JG. Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distension in humans. Journal of Clinical Endocrinology and Metabolism 1989 68 837-843.
123. Swaab DF, Purba JS & Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi Syndrome: a study of five cases. Journal of Clinical Endocrinology and Metabolism 1995 80 573-579.
124. Demitrack MA, Lesem MD, Listwak SJ, Brandt HA, Jimerson DC & Gold PW. CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations. American Journal of Psychiatry 1990 147 882-886.
125. Yang J. Intrathecal administration of oxytocin induces analgesia in low back pain involving the endogenous opiate peptide system. Spine 1994 19 867-871.
126. Alfvén G, de la Torre B & Uvnäs-Moberg K. Depressed concentrations of oxytocin and cortisol in children with recurrent abdominal pain of non-organic origin. Acta Paediatrica 1994 83 1076-1080.
127. Purba JS, Hofman MA, Portegies P, Troost D & Swaab DF. Decreased number of oxytocin neurons in the paraventricular nucleus of the human hypothalamus in AIDS. Brain 1993 116 795-809.
128. Purba JS, Hofman MA & Swaab DF. Decreased number of oxytocin-immunoreactive neurons in the paraventricular nucleus of the hypothalamus in Parkinson's disease. Neurology 1994 44 84-89.
129. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Archives of General Psychiatry 1994 51 782-792.
130. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT & DeLong MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982 215 1237-1238.
131. Mazurek MF, Beal MF, Bird ED & Martin JB. Oxytocin in Alzheimer's disease: postmortem brain levels. Neurology 1987 37 1001-1003.
132. Purba JS, Haagendijk WJ, Hofman MA & Swaab DF. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Archives of General Psychiatry 1996 53 137-143.
133. Frasch A, Zetzsche T, Steiger A & Jirikowski GF. Reduction of plasma oxytocin levels in patients suffering from major depression. Advances in Experimental Medicine and Biology 1995 395 257-258.
134. Uvnäs-Moberg K. Oxytocin and behaviour. Annals of Medicine 1994 26 315-317.
135. Sausville E, Carney D & Battey J. The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. Journal of Biological Chemistry 1985 260 10236-10241.
136. Murphy MR, Checkley SA, Seckl JR & Lightman SL. Naloxone inhibits oxytocin release at orgasm in man. Journal of Clinical Endocrinology and Metabolism 1990 71 1056-1058.